Cholesterol dependence of Newcastle Disease Virus entry

Departamento de Bioquimica, Universidad de Salamanca, Salamanca, Spain.
Biochimica et Biophysica Acta (Impact Factor: 4.66). 12/2011; 1818(3):753-61. DOI: 10.1016/j.bbamem.2011.12.004
Source: PubMed

ABSTRACT Lipid rafts are membrane microdomains enriched in cholesterol, sphingolipids, and glycolipids that have been implicated in many biological processes. Since cholesterol is known to play a key role in the entry of some other viruses, we investigated the role of cholesterol and lipid rafts in the host cell plasma membrane in Newcastle Disease Virus (NDV) entry. We used methyl-β-cyclodextrin (MβCD) to deplete cellular cholesterol and disrupt lipid rafts. Our results show that the removal of cellular cholesterol partially reduces viral binding, fusion and infectivity. MβCD had no effect on the expression of sialic acid containing molecule expression, the NDV receptors in the target cell. All the above-described effects were reversed by restoring cholesterol levels in the target cell membrane. The HN viral attachment protein partially localized to detergent-resistant membrane microdomains (DRMs) at 4°C and then shifted to detergent-soluble fractions at 37°C. These results indicate that cellular cholesterol may be required for optimal cell entry in NDV infection cycle.

Download full-text


Available from: Isabel Muñoz-Barroso, Sep 01, 2015
  • Source
    • "Therefore, some viruses are potentially contained within small invaginations in the plasma membranes of host cell that form the caveosome, which delivers virus particles to early endosomes (Figure 3) within the infected cells [66]. Cantín et al. [64] described the colocalization of NDV with caveolin and with the early endosome marker EEA1, leading to the suggestion that a certain percentage of the virus manages to penetrate the cell through caveolin-dependent endocytic pathways [67]. In that particular study, after 30 minutes of NDV infection, a strong colocalization of NDV HN protein and EEA1 was found, thus confirming that HN is targeted to early endosomes. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Glioblastoma multiforme (GBM), or grade IV glioma, is one of the most lethal forms of human brain cancer. Current bioscience has begun to depict more clearly the signalling pathways that are responsible for high-grade glioma initiation, migration, and invasion, opening the door for molecular-based targeted therapy. As such, the application of viruses such as Newcastle disease virus (NDV) as a novel biological bullet to specifically target aberrant signalling in GBM has brought new hope. The abnormal proliferation and aggressive invasion behaviour of GBM is reported to be associated with aberrant Rac1 protein signalling. NDV interacts with Rac1 upon viral entry, syncytium induction, and actin reorganization of the infected cell as part of the replication process. Ultimately, intracellular stress leads the infected glioma cell to undergo cell death. In this review, we describe the characteristics of malignant glioma and the aberrant genetics that drive its aggressive phenotype, and we focus on the use of oncolytic NDV in GBM-targeted therapy and the interaction of NDV in GBM signalling that leads to inhibition of GBM proliferation and invasion, and subsequently, cell death.
    BioMed Research International 08/2014; 2014:386470. DOI:10.1155/2014/386470 · 2.71 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Receptor recognition and binding is the first step in the viral cycle. It has been established that Newcastle Disease Virus (NDV) interacts with sialylated molecules such as gangliosides and glycoproteins at the cell surface. Nevertheless, the specific receptor(s) that mediate virus entry are not well known. We have analysed the role of the sialic acid linkage in the early steps of the viral infection cycle. Pretreatment of ELL-0 cells with both α2,3 and α2,6 specific sialidases led to the inhibition of NDV binding, fusion and infectivity, which were restored after α2,3(N)- and α2,6(N)-sialyltransferase incubation. Moreover, α2,6(N)-sialyltransferases also restored NDV activities in α2-6-linked sialic acid deficient cells. Competition with α2-6 sialic acid-binding lectins led to a reduction in the three NDV activities (binding, fusion and infectivity) suggesting a role for α2-6- linked sialic acid in NDV entry. We conclude that both α2-3- and α2-6- linked sialic acid containing glycoconjugates may be used for NDV infection. NDV was able to efficiently bind, fuse and infect the ganglioside-deficient cell line GM95 to a similar extent to that of its parental MEB4, suggesting that gangliosides are not essential for NDV binding, fusion and infectivity. Nevertheless, the fact that the interaction of NDV with cells deficient in N-glycoprotein expression such as Lec1 was less efficient prompted us to conclude that NDV requires N-linked glycoproteins for efficient attachment and entry into the host cell.
    Glycoconjugate Journal 08/2012; 29(7):539-49. DOI:10.1007/s10719-012-9431-0 · 1.95 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: In previous work, we have designed peptides which showed potent inhibition of Newcastle Disease Virus (NDV) and Infectious Bronchitis Virus (IBV) infections in chicken embryos. In this present study, we demonstrate that peptides modified using cholesterol or 3 units of polyethylene glycol (PEG3) conjugated to the peptides' N-terminus presented even more promising antiviral activities when tested in animal models. Both cholesterol and cholesterol-PEG3 tagged peptides were able to protect chicken embryos from infections of different serotypes of NDV and IBV when administered 12 hours prior to virus inoculation. In comparison, un-tagged peptide required intervention closer to the time of viral inoculation to achieve a similar protection. Intramuscular injection of cholesterol-tagged peptide at 1.6 mg/kg one day before virus infection and then once every 3 days for 3 times after viral inoculation protected 70% of the chickens from NDV infection. We further demonstrate that the cholesterol-tagged peptide has an extended in-vivo half-life as compared to un-tagged peptides. It also has the potential to cross the blood-brain barrier to enter the avian central nervous system (CNS). Finally, we show that the cholesterol-tagged peptide could play a role before the viral fusion peptide insertion into the host cell, and thereby target an earlier stage in fusion glycoprotein activation. Our findings are of importance for further development of antivirals with broad-spectrum protective effects.
    Journal of Virology 06/2013; 87(16). DOI:10.1128/JVI.01153-13 · 4.65 Impact Factor
Show more